Wunderlich C - Search Results

1

Stored red blood cells impair vascular function in vivo.

Forkmann M, Christoph M, Ibrahim K, Swoboda M, Kolschmann S, Strasser RH, Wunderlich C. Forkmann M, et al. Among authors: wunderlich c. Transfusion. 2014 Jan;54(1):255. doi: 10.1111/trf.12436. Transfusion. 2014. PMID: 24405307 No abstract available.

2

Severe aortic regurgitation in Ehlers-Danlos syndrome type IV.

Wunderlich C, Schulze MR, Strasser RH. Wunderlich C, et al. Heart. 2005 Jan;91(1):126. doi: 10.1136/hrt.2004.035097. Heart. 2005. PMID: 15604357 Free PMC article. No abstract available.

3

Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure.

Wunderlich C, Schober K, Lange SA, Drab M, Braun-Dullaeus RC, Kasper M, Schwencke C, Schmeisser A, Strasser RH. Wunderlich C, et al. Biochem Biophys Res Commun. 2006 Feb 10;340(2):702-8. doi: 10.1016/j.bbrc.2005.12.058. Epub 2005 Dec 20. Biochem Biophys Res Commun. 2006. PMID: 16380094

4

Caveolae and caveolin in transmembrane signaling: Implications for human disease.

Schwencke C, Braun-Dullaeus RC, Wunderlich C, Strasser RH. Schwencke C, et al. Among authors: wunderlich c. Cardiovasc Res. 2006 Apr 1;70(1):42-9. doi: 10.1016/j.cardiores.2005.11.029. Epub 2006 Jan 10. Cardiovasc Res. 2006. PMID: 16412403 Review.

5

Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.

Lange SA, Wolf B, Schober K, Wunderlich C, Marquetant R, Weinbrenner C, Strasser RH. Lange SA, et al. Among authors: wunderlich c. J Cardiovasc Pharmacol. 2007 Jan;49(1):46-55. doi: 10.1097/FJC.0b013e31802c2f77. J Cardiovasc Pharmacol. 2007. PMID: 17261963

6

Ortner's syndrome or cardiovocal hoarseness.

Wunderlich C, Wunderlich O, Tausche AK, Fuhrmann J, Boscheri A, Strasser RH. Wunderlich C, et al. Among authors: wunderlich o. Intern Med J. 2007 Jun;37(6):418-9. doi: 10.1111/j.1445-5994.2007.01341.x. Intern Med J. 2007. PMID: 17535390 No abstract available.

7

Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.

Wunderlich C, Schmeisser A, Heerwagen C, Ebner B, Schober K, Braun-Dullaeus RC, Schwencke C, Kasper M, Morawietz H, Strasser RH. Wunderlich C, et al. Pulm Pharmacol Ther. 2008;21(3):507-15. doi: 10.1016/j.pupt.2007.11.005. Epub 2007 Dec 8. Pulm Pharmacol Ther. 2008. PMID: 18226570

8

The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.

Wunderlich C, Schober K, Schmeisser A, Heerwagen C, Tausche AK, Steinbronn N, Brandt A, Kasper M, Schwencke C, Braun-Dullaeus RC, Strasser RH. Wunderlich C, et al. J Mol Cell Cardiol. 2008 May;44(5):938-47. doi: 10.1016/j.yjmcc.2008.02.275. Epub 2008 Mar 8. J Mol Cell Cardiol. 2008. PMID: 18417152

9

Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.

Fuhrmann JT, Schmeisser A, Schulze MR, Wunderlich C, Schoen SP, Rauwolf T, Weinbrenner C, Strasser RH. Fuhrmann JT, et al. Among authors: wunderlich c. Crit Care Med. 2008 Aug;36(8):2257-66. doi: 10.1097/CCM.0b013e3181809846. Crit Care Med. 2008. PMID: 18664782 Clinical Trial.

10

Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice.

Wunderlich C, Schober K, Kasper M, Heerwagen C, Marquetant R, Ebner B, Forkmann M, Schoen S, Braun-Dullaeus RC, Schmeisser A, Strasser RH. Wunderlich C, et al. Biochem Biophys Res Commun. 2008 Dec 19;377(3):769-74. doi: 10.1016/j.bbrc.2008.10.068. Epub 2008 Oct 23. Biochem Biophys Res Commun. 2008. PMID: 18951881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters